AZN
Price
$81.70
Change
-$0.08 (-0.10%)
Updated
Sep 5 closing price
Capitalization
251.96B
60 days until earnings call
AZNCF
Price
$164.50
Change
+$2.50 (+1.54%)
Updated
Sep 5 closing price
Capitalization
251.96B
Interact to see
Advertisement

AZN vs AZNCF

Header iconAZN vs AZNCF Comparison
Open Charts AZN vs AZNCFBanner chart's image
AstraZeneca
Price$81.70
Change-$0.08 (-0.10%)
Volume$2.46M
Capitalization251.96B
AstraZeneca
Price$164.50
Change+$2.50 (+1.54%)
Volume$569
Capitalization251.96B
AZN vs AZNCF Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. AZNCF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Hold and AZNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AZN: $81.70 vs. AZNCF: $164.50)
Brand notoriety: AZN: Notable vs. AZNCF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 55% vs. AZNCF: 15%
Market capitalization -- AZN: $251.96B vs. AZNCF: $251.96B
AZN [@Pharmaceuticals: Major] is valued at $251.96B. AZNCF’s [@Pharmaceuticals: Major] market capitalization is $251.96B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileAZNCF’s FA Score has 1 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • AZNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, both AZN and AZNCF are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 2 TA indicator(s) are bullish while AZNCF’s TA Score has 5 bullish TA indicator(s).

  • AZN’s TA Score: 2 bullish, 5 bearish.
  • AZNCF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AZNCF is a better buy in the short-term than AZN.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +2.25% price change this week, while AZNCF (@Pharmaceuticals: Major) price change was +2.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.16%. For the same industry, the average monthly price growth was +3.94%, and the average quarterly price growth was +10.41%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($252B) and AZNCF($252B) have the same market capitalization . AZNCF (30.98) and AZN (30.77) have similar P/E ratio . AZN (27.355) and AZNCF (26.538) have similar YTD gains . AZNCF has more cash in the bank: 7.11B vs. AZN (1.41B). AZN (32.8B) and AZNCF (32.8B) have identical debt.
AZNAZNCFAZN / AZNCF
Capitalization252B252B100%
EBITDAN/A16.8B-
Gain YTD27.35526.538103%
P/E Ratio30.7730.9899%
RevenueN/A56.5B-
Total Cash1.41B7.11B20%
Total Debt32.8B32.8B100%
FUNDAMENTALS RATINGS
AZN vs AZNCF: Fundamental Ratings
AZN
AZNCF
OUTLOOK RATING
1..100
3150
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
3443
SMR RATING
1..100
4646
PRICE GROWTH RATING
1..100
4948
P/E GROWTH RATING
1..100
8079
SEASONALITY SCORE
1..100
7565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZNCF's Valuation (23) in the null industry is in the same range as AZN (24) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (34) in the Pharmaceuticals Major industry is in the same range as AZNCF (43) in the null industry. This means that AZN’s stock grew similarly to AZNCF’s over the last 12 months.

AZN's SMR Rating (46) in the Pharmaceuticals Major industry is in the same range as AZNCF (46) in the null industry. This means that AZN’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's Price Growth Rating (48) in the null industry is in the same range as AZN (49) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to AZN’s over the last 12 months.

AZNCF's P/E Growth Rating (79) in the null industry is in the same range as AZN (80) in the Pharmaceuticals Major industry. This means that AZNCF’s stock grew similarly to AZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNAZNCF
RSI
ODDS (%)
Bearish Trend 3 days ago
40%
Bearish Trend 3 days ago
40%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
40%
Bearish Trend 3 days ago
64%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
50%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 5 days ago
55%
Bullish Trend 25 days ago
64%
Declines
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend about 1 month ago
50%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
50%
Aroon
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITB1.860.11
+6.29%
LightInTheBox Holding Co Ltd
VRTX396.12-0.81
-0.20%
Vertex Pharmaceuticals
IRTC181.05-1.12
-0.61%
iRhythm Technologies
OBK38.65-0.44
-1.13%
Origin Bancorp
SSP2.95-0.06
-1.99%
EW Scripps Company (The)

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.10%
GSK - AZN
62%
Loosely correlated
+2.25%
NVS - AZN
61%
Loosely correlated
+1.02%
SNY - AZN
46%
Loosely correlated
+2.58%
PFE - AZN
45%
Loosely correlated
+1.39%
LLY - AZN
40%
Loosely correlated
-2.11%
More

AZNCF and

Correlation & Price change

A.I.dvisor tells us that AZNCF and BAYRY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AZNCF and BAYRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZNCF
1D Price
Change %
AZNCF100%
+1.54%
BAYRY - AZNCF
20%
Poorly correlated
-1.08%
AZN - AZNCF
16%
Poorly correlated
-0.10%
ABBV - AZNCF
9%
Poorly correlated
-0.21%
ALPMY - AZNCF
9%
Poorly correlated
+1.59%
ALPMF - AZNCF
7%
Poorly correlated
+1.05%
More